🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 6

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 6 of 20
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
May 1, 2024 at 7:40 PM#26

Adding the numbers, since they settle part of this. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

33 6VendorMark, COA_Karl, MikeFit_NJ and 30 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
May 10, 2024 at 9:52 AM#27

Following on from claudia_zurich — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

34 7roxy_nash, tony_orlando, Dr.NephBHM_UK and 31 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
May 18, 2024 at 11:59 PM#28
DataDave said:
Keep the original post as written when you update it, and add the correction underneath.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

Last edited: May 19, 2024 at 12:59 AM
35 8TomTeleRx, DoseLogDan, SleepFixSam and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
May 27, 2024 at 2:01 PM#29
DataDave said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

36 9sarah_nash92, FitDadDave, RunnerRach and 33 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 5, 2024 at 3:58 AM#30

Closing the loop on my own question.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

8 6lori_vegas, Dr.PulmRoch, maya_sedona and 5 others
Reply Quote Save Share Report
14567820

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register